Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for CGEM

Stock Name	Cullinan Oncology LLC
Ticker	CGEM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages: Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025: (RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc: Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP: ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.: American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CGEM holdings

Date	Number of CGEM Shares Held	Base Market Value of CGEM Shares	Local Market Value of CGEM Shares	Change in CGEM Shares Held	Change in CGEM Base Value	Current Price per CGEM Share Held	Previous Price per CGEM Share Held
2025-09-26 (Friday)	17,513	USD 104,377	USD 104,377
2025-09-25 (Thursday)	17,513	USD 104,903	USD 104,903	0	USD -700	USD 5.99001	USD 6.02998
2025-09-24 (Wednesday)	17,513	USD 105,603	USD 105,603
2025-09-17 (Wednesday)	17,401	USD 103,188	USD 103,188	0	USD -6,264	USD 5.93	USD 6.28998
2025-09-16 (Tuesday)	17,401	USD 109,452	USD 109,452
2025-09-12 (Friday)	17,289	USD 112,897	USD 112,897
2025-09-11 (Thursday)	17,289	USD 114,453	USD 114,453

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00B3VWM098

Show aggregate share trades of CGEM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -56 7.670* 9.65 Profit of 540 on sale
2025-07-31 BUY 168 7.770* 9.68
2025-06-30 SELL -112 7.530* 9.92 Profit of 1,111 on sale
2025-06-25 SELL -56 7.920* 9.96 Profit of 558 on sale
2025-06-20 SELL -112 7.670* 10.01 Profit of 1,121 on sale
2025-05-23 BUY 56 7.810* 10.26
2025-05-19 SELL -56 7.710* 10.34 Profit of 579 on sale
2025-05-15 SELL -168 7.240* 10.39 Profit of 1,746 on sale
2025-05-12 SELL -56 7.910* 10.47 Profit of 586 on sale
2025-05-09 SELL -56 7.540* 10.50 Profit of 588 on sale
2025-04-30 SELL -56 8.280* 10.65 Profit of 597 on sale
2025-04-24 SELL -112 8.140* 10.76 Profit of 1,205 on sale
2025-04-17 SELL -56 7.890* 10.90 Profit of 611 on sale
2025-04-15 SELL -168 7.800* 10.97 Profit of 1,843 on sale
2025-04-14 SELL -168 7.740* 11.01 Profit of 1,849 on sale
2025-04-09 SELL -224 7.790* 11.12 Profit of 2,491 on sale
2025-04-07 SELL -392 7.250* 11.21 Profit of 4,394 on sale
2025-04-04 SELL -560 7.410* 11.25 Profit of 6,302 on sale
2025-03-31 BUY 56 7.570* 11.39
2025-03-19 SELL -112 8.650* 11.71 Profit of 1,312 on sale
2025-03-14 SELL -336 8.790* 11.83 Profit of 3,974 on sale
2025-03-13 SELL -114 8.920* 11.87 Profit of 1,353 on sale
2025-03-12 SELL -1,938 9.080* 11.91 Profit of 23,082 on sale
2025-03-07 SELL -114 8.710* 12.06 Profit of 1,375 on sale
2025-03-06 SELL -171 8.510* 12.12 Profit of 2,072 on sale
2025-03-03 SELL -57 8.000* 12.31 Profit of 702 on sale
2025-02-28 SELL -41,041 8.490* 12.37 Profit of 507,785 on sale
2025-02-26 SELL -164 8.450* 12.50 Profit of 2,050 on sale
2025-02-25 SELL -492 8.560* 12.57 Profit of 6,185 on sale
2025-02-18 BUY 820 9.260* 12.90
2025-02-13 BUY 164 9.590* 13.10
2025-02-12 BUY 164 9.890* 13.16
2025-02-11 BUY 492 9.810* 13.23
2025-02-06 BUY 1,476 10.350* 13.43
2025-01-27 BUY 164 10.300* 14.07
2024-12-30 BUY 820 12.200* 14.39
2024-12-06 BUY 656 13.060* 14.55
2024-12-05 BUY 164 12.440* 14.62
2024-12-04 BUY 820 12.960* 14.68
2024-11-29 BUY 820 13.450* 14.86
2024-11-27 BUY 656 13.090* 15.02
2024-11-26 BUY 164 12.770* 15.12
2024-11-21 BUY 820 12.220* 15.54
2024-11-20 BUY 492 12.580* 15.71
2024-11-18 BUY 1,963 13.450* 16.01
2024-11-12 BUY 1,304 16.020* 16.01
2024-11-08 BUY 815 16.020* 16.01
2024-11-07 BUY 2,445 15.580* 16.04
2024-11-06 BUY 326 16.480* 16.01
2024-10-31 BUY 163 15.550* 16.11
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-56	7.670*	9.65 Profit of 540 on sale
2025-07-31	BUY	168	7.770*	9.68
2025-06-30	SELL	-112	7.530*	9.92 Profit of 1,111 on sale
2025-06-25	SELL	-56	7.920*	9.96 Profit of 558 on sale
2025-06-20	SELL	-112	7.670*	10.01 Profit of 1,121 on sale
2025-05-23	BUY	56	7.810*	10.26
2025-05-19	SELL	-56	7.710*	10.34 Profit of 579 on sale
2025-05-15	SELL	-168	7.240*	10.39 Profit of 1,746 on sale
2025-05-12	SELL	-56	7.910*	10.47 Profit of 586 on sale
2025-05-09	SELL	-56	7.540*	10.50 Profit of 588 on sale
2025-04-30	SELL	-56	8.280*	10.65 Profit of 597 on sale
2025-04-24	SELL	-112	8.140*	10.76 Profit of 1,205 on sale
2025-04-17	SELL	-56	7.890*	10.90 Profit of 611 on sale
2025-04-15	SELL	-168	7.800*	10.97 Profit of 1,843 on sale
2025-04-14	SELL	-168	7.740*	11.01 Profit of 1,849 on sale
2025-04-09	SELL	-224	7.790*	11.12 Profit of 2,491 on sale
2025-04-07	SELL	-392	7.250*	11.21 Profit of 4,394 on sale
2025-04-04	SELL	-560	7.410*	11.25 Profit of 6,302 on sale
2025-03-31	BUY	56	7.570*	11.39
2025-03-19	SELL	-112	8.650*	11.71 Profit of 1,312 on sale
2025-03-14	SELL	-336	8.790*	11.83 Profit of 3,974 on sale
2025-03-13	SELL	-114	8.920*	11.87 Profit of 1,353 on sale
2025-03-12	SELL	-1,938	9.080*	11.91 Profit of 23,082 on sale
2025-03-07	SELL	-114	8.710*	12.06 Profit of 1,375 on sale
2025-03-06	SELL	-171	8.510*	12.12 Profit of 2,072 on sale
2025-03-03	SELL	-57	8.000*	12.31 Profit of 702 on sale
2025-02-28	SELL	-41,041	8.490*	12.37 Profit of 507,785 on sale
2025-02-26	SELL	-164	8.450*	12.50 Profit of 2,050 on sale
2025-02-25	SELL	-492	8.560*	12.57 Profit of 6,185 on sale
2025-02-18	BUY	820	9.260*	12.90
2025-02-13	BUY	164	9.590*	13.10
2025-02-12	BUY	164	9.890*	13.16
2025-02-11	BUY	492	9.810*	13.23
2025-02-06	BUY	1,476	10.350*	13.43
2025-01-27	BUY	164	10.300*	14.07
2024-12-30	BUY	820	12.200*	14.39
2024-12-06	BUY	656	13.060*	14.55
2024-12-05	BUY	164	12.440*	14.62
2024-12-04	BUY	820	12.960*	14.68
2024-11-29	BUY	820	13.450*	14.86
2024-11-27	BUY	656	13.090*	15.02
2024-11-26	BUY	164	12.770*	15.12
2024-11-21	BUY	820	12.220*	15.54
2024-11-20	BUY	492	12.580*	15.71
2024-11-18	BUY	1,963	13.450*	16.01
2024-11-12	BUY	1,304	16.020*	16.01
2024-11-08	BUY	815	16.020*	16.01
2024-11-07	BUY	2,445	15.580*	16.04
2024-11-06	BUY	326	16.480*	16.01
2024-10-31	BUY	163	15.550*	16.11

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	91,713	0	453,137	20.2%
2025-09-18	29,909	64	374,322	8.0%
2025-09-17	29,113	561	152,081	19.1%
2025-09-16	41,765	2	156,366	26.7%
2025-09-15	69,037	556	213,450	32.3%
2025-09-12	76,084	0	383,502	19.8%
2025-09-11	66,615	867	581,520	11.5%
2025-09-10	55,097	0	308,725	17.8%
2025-09-09	106,491	0	278,733	38.2%
2025-09-08	44,979	0	172,182	26.1%
2025-09-05	92,584	2,960	314,975	29.4%
2025-09-04	218,977	13,252	745,971	29.4%
2025-09-03	59,535	0	162,544	36.6%
2025-09-02	30,215	0	107,256	28.2%
2025-08-29	28,955	0	102,690	28.2%
2025-08-28	39,008	0	89,895	43.4%
2025-08-27	50,544	0	153,481	32.9%
2025-08-26	38,684	3	378,657	10.2%
2025-08-25	17,620	0	58,531	30.1%
2025-08-22	73,100	0	173,435	42.1%
2025-08-21	27,559	0	85,312	32.3%
2025-08-20	37,739	0	91,418	41.3%
2025-08-19	37,960	0	83,526	45.4%
2025-08-18	77,212	0	180,135	42.9%
2025-08-15	37,996	0	114,067	33.3%
2025-08-14	15,179	0	186,706	8.1%
2025-08-13	25,903	0	130,511	19.8%
2025-08-12	44,973	0	119,053	37.8%
2025-08-11	41,962	128	103,183	40.7%
2025-08-08	67,304	2,573	153,714	43.8%
2025-08-07	80,102	176	173,936	46.1%
2025-08-06	21,373	0	51,516	41.5%
2025-08-05	22,741	0	58,650	38.8%
2025-08-04	26,114	0	93,276	28.0%
2025-08-01	38,240	579	76,874	49.7%
2025-07-31	35,027	58	68,864	50.9%
2025-07-30	80,500	0	739,899	10.9%
2025-07-29	58,393	9	130,459	44.8%
2025-07-28	27,557	0	46,548	59.2%
2025-07-25	21,736	176	36,209	60.0%
2025-07-24	54,730	18	130,095	42.1%
2025-07-23	77,967	0	133,955	58.2%
2025-07-22	49,802	0	89,671	55.5%
2025-07-21	27,480	0	40,112	68.5%
2025-07-18	29,606	0	50,251	58.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE